TSE:CRON Cronos Group (CRON) Stock Price, News & Analysis → “Retirement Secret” Showed 995% Gain Last Time We Shared It (From Stansberry Research) (Ad) Free CRON Stock Alerts C$3.44 +0.03 (+0.88%) (As of 04/25/2024 ET) Add Compare Share Share Today's RangeC$3.35▼C$3.4650-Day RangeC$2.62▼C$3.8952-Week RangeC$2.15▼C$4.01Volume63,063 shsAverage Volume207,734 shsMarket CapitalizationC$1.31 billionP/E RatioN/ADividend YieldN/APrice TargetC$2.77 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsHeadlines Get Cronos Group alerts: Email Address Cronos Group MarketRank™ Stock AnalysisAnalyst RatingHold2.00 Rating ScoreUpside/Downside19.5% DownsideC$2.77 Price TargetShort InterestN/ADividend StrengthN/ASustainabilityN/ANews Sentiment0.35Based on 3 Articles This WeekInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.33 out of 5 stars 1.0 Analyst's Opinion Consensus RatingCronos Group has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 2 hold ratings, and no sell ratings.Amount of Analyst CoverageCronos Group has only been the subject of 1 research reports in the past 90 days. Previous Next N/A Short Interest Short InterestThere is no current short interest data available for CRON. Previous Next 0.0 Dividend Strength Dividend YieldCronos Group does not currently pay a dividend.Dividend GrowthCronos Group does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for CRON. Previous Next 2.4 News and Social Media Coverage News SentimentCronos Group has a news sentiment score of 0.35. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Cronos Group this week, compared to 1 article on an average week.Search InterestOnly 12 people have searched for CRON on MarketBeat in the last 30 days. This is a decrease of -20% compared to the previous 30 days.MarketBeat Follows1 people have added Cronos Group to their MarketBeat watchlist in the last 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Cronos Group insiders have not sold or bought any company stock.Percentage Held by Insiders46.65% of the stock of Cronos Group is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 13.13% of the stock of Cronos Group is held by institutions. Previous Next 1.3 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Cronos Group is -14.33, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Cronos Group is -14.33, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioCronos Group has a PEG Ratio of 0.12. PEG Ratios below 1 indicate that a company could be undervalued.Price to Book Value per Share RatioCronos Group has a P/B Ratio of 1.19. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Stansberry Research“Retirement Secret” Showed 995% Gain Last Time We Shared ItCentral Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.Find out why right here (and see what you can do to get in too with just a few dollars). About Cronos Group Stock (TSE:CRON)Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.Read More CRON Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CRON Stock News HeadlinesApril 26, 2024 | msn.comChinese Financial Services Shares Gain on Consolidation HopesApril 21, 2024 | finance.yahoo.comSannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage EffectApril 26, 2024 | Stansberry Research (Ad)“Retirement Secret” Showed 995% Gain Last Time We Shared ItCentral Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.April 19, 2024 | finance.yahoo.comCronos Group Inc.'s (TSE:CRON) Shift From Loss To ProfitApril 18, 2024 | investing.comKPMG to exit cannabis industry audits, Cronos seeks new firmMarch 25, 2024 | finance.yahoo.comCronos Group Inc. Ontario Securities Class Action NoticeMarch 18, 2024 | msn.com1 High-Yield Dividend King to Scoop Up While It's CheapMarch 16, 2024 | finance.yahoo.comCRON Oct 2024 2.500 putApril 26, 2024 | Stansberry Research (Ad)“Retirement Secret” Showed 995% Gain Last Time We Shared ItCentral Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.March 15, 2024 | benzinga.comSmart Money Is Betting Big In Altria Group OptionsMarch 1, 2024 | finance.yahoo.comCronos Group Inc. (NASDAQ:CRON) Q4 2023 Earnings Call TranscriptFebruary 20, 2024 | msn.comLaw enforcement agencies disrupt prolific ransomware group LockBitFebruary 19, 2024 | msn.comLockbit cybercrime gang disrupted by international police operationFebruary 19, 2024 | msn.comLockBit ransomware gang disrupted by global operationFebruary 15, 2024 | msn.comThe highs and lows of yeast-derived cannabisFebruary 15, 2024 | msn.comEni drills second well at Cronos gas discovery off CyprusFebruary 15, 2024 | msn.com‘Excellent’ Cronos gas discovery off CyprusFebruary 14, 2024 | finance.yahoo.comCronos Group Inc. to Hold 2023 Fourth Quarter and Full-Year Earnings Conference Call on February 29, 2024February 13, 2024 | morningstar.comCronos Group Inc CRONFebruary 5, 2024 | investing.comCronos Group Inc (CRON)February 3, 2024 | finance.yahoo.comWhile public companies own 41% of Cronos Group Inc. (TSE:CRON), retail investors are its largest shareholders with 44% ownershipFebruary 1, 2024 | finance.yahoo.comMurray R. Garnick, Executive Vice President & General Counsel, Announces Decision to RetireJanuary 25, 2024 | finance.yahoo.comCronos’ Spinach® Brand Ends 2023 as the Number One Flower Brand in Canada1January 9, 2024 | msn.comCanadian Cannabis Co. Cronos Explores Untapped Potential In Australia's Marijuana IndustryJanuary 9, 2024 | finance.yahoo.comCronos Enters Australian Cannabis MarketDecember 28, 2023 | markets.businessinsider.comCronos Group Sell Rating Affirmed Amid Modest Sales Forecasts and Competitive ChallengesDecember 28, 2023 | markets.businessinsider.comB of A Securities Maintains Underperform Rating for Cronos Group: Here's What You Need To KnowSee More Headlines Receive CRON Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cronos Group and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/26/2024Next Earnings (Estimated)5/07/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeTSE SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolTSE:CRON CUSIPN/A CIKN/A Webwww.thecronosgroup.com Phone416-504-0004FaxN/AEmployees356Year FoundedN/APrice Target and Rating Average Stock Price TargetC$2.77 High Stock Price TargetC$2.82 Low Stock Price TargetC$2.72 Potential Upside/Downside-19.5%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)C($0.24) Trailing P/E RatioN/A Forward P/E RatioN/A P/E Growth0.12Net IncomeC$-69,850,000.00 Net Margins-84.78% Pretax MarginN/A Return on Equity-6.30% Return on Assets-4.24% Debt Debt-to-Equity Ratio0.23 Current Ratio22.54 Quick Ratio24.01 Sales & Book Value Annual SalesC$87.24 million Price / Sales15.04 Cash FlowC$2.06 per share Price / Cash Flow1.67 Book ValueC$2.88 per share Price / Book1.19Miscellaneous Outstanding Shares381,300,000Free FloatN/AMarket CapC$1.31 billion OptionableNot Optionable Beta1.04 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report Key ExecutivesMr. Michael Ryan Gorenstein J.D. (Age 37)President, CEO & Chairman Comp: $5.35MMr. James Holm (Age 41)Chief Financial Officer Comp: $426.9kMr. Jeffrey David Jacobson (Age 38)Chief Growth Officer Comp: $991.66kMs. Anna Shlimak (Age 38)Senior Vice President of Corporate Affairs & Strategy Comp: $720.54kMr. James Andrew McGinness III (Age 45)VP, Controller & Principal Accounting Officer Mr. Shayne J. LaidlawDirector of Investor Relations & StrategyMr. Terry Gregory-Joseph Doucet (Age 34)General Counsel & Corporate Secretary Ms. Shannon Buggy (Age 54)Senior VP & Global Head of People Comp: $596kMr. Arye Weigensberg (Age 41)Senior VP & Head of Research and Development More ExecutivesKey CompetitorsCanopy GrowthTSE:WEEDHydropothecaryCVE:THCXTilray BrandsTSE:TLRYKnight TherapeuticsTSE:GUDAurora CannabisTSE:ACBView All Competitors CRON Stock Analysis - Frequently Asked Questions Should I buy or sell Cronos Group stock right now? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cronos Group in the last year. There are currently 2 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" CRON shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CRON, but not buy additional shares or sell existing shares. View CRON analyst ratings or view top-rated stocks. What is Cronos Group's stock price target for 2024? 2 equities research analysts have issued 1-year price objectives for Cronos Group's shares. Their CRON share price targets range from C$2.72 to C$2.82. On average, they predict the company's share price to reach C$2.77 in the next twelve months. This suggests that the stock has a possible downside of 19.5%. View analysts price targets for CRON or view top-rated stocks among Wall Street analysts. How have CRON shares performed in 2024? Cronos Group's stock was trading at C$2.77 at the beginning of 2024. Since then, CRON shares have increased by 24.2% and is now trading at C$3.44. View the best growth stocks for 2024 here. When is Cronos Group's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 7th 2024. View our CRON earnings forecast. What other stocks do shareholders of Cronos Group own? Based on aggregate information from My MarketBeat watchlists, some companies that other Cronos Group investors own include Aurora Cannabis (ACB), Canopy Growth (WEED), NVIDIA (NVDA), Aphria (APHA), Advanced Micro Devices (AMD), Netflix (NFLX), Walt Disney (DIS) and Intel (INTC). How do I buy shares of Cronos Group? Shares of CRON stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (TSE:CRON) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsThe World's First "$20 Trillion Drug?"Behind the MarketsI’m afraid WWIII is a very real possibility Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cronos Group Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.